SCHEMBL6254945

SCHEMBL6254945

Fc1ccc(CCCN2CCN(CCOC(c3ccccc3)c3ccccc3)CC2)cc1

nearest known ligand 0.90

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 7/20 0.90
SLC6A3 Q01959 7/20 0.90
SLC6A2 P23975 5/20 0.90
SMN1; SMN2 Q16637 4/20 0.90
SIGMAR1 Q99720 4/20 0.90
MAPK1 P28482 3/20 0.90
MEN1 O00255 3/20 0.90
ALDH1A1 P00352 3/20 0.90
LMNA P02545 3/20 0.90
KMT2A Q03164 3/20 0.90
CYP2D6 P10635 3/20 0.90
TDP1 Q9NUW8 2/20 0.90
TP53 P04637 2/20 0.90
CYP1A2 P05177 2/20 0.90
MAPT P10636 2/20 0.90
CYP2C9 P11712 2/20 0.90
TSHR P16473 2/20 0.90
NFKB1 P19838 2/20 0.90
CYP2C19 P33261 2/20 0.90
THPO P40225 2/20 0.90

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11374533 0.99 SLC6A4 (0.90) SLC6A4SLC6A3SLC6A2SMN1; SMN2SIGMAR1
SCHEMBL10000765 0.96 SLC6A4 (0.97) SLC6A4SLC6A3SLC6A2SMN1; SMN2SIGMAR1
Vanoxerine SCHEMBL246574 0.95 SLC6A4 (1.00) SLC6A4SLC6A3SLC6A2SMN1; SMN2SIGMAR1
Vanoxerine SCHEMBL725103 0.94 SLC6A4 (1.00) SLC6A4SLC6A3SLC6A2SMN1; SMN2SIGMAR1
Vanoxerine SCHEMBL15541249 0.94 SLC6A4 (1.00) SLC6A4SLC6A3SLC6A2SMN1; SMN2SIGMAR1
Vanoxerine SCHEMBL3014060 0.92 SLC6A4 (0.95) SLC6A4SLC6A3SLC6A2SMN1; SMN2SIGMAR1
Hydrochloric Acid SCHEMBL11380714 0.92 SLC6A4 (0.88) SLC6A4SLC6A3SLC6A2SMN1; SMN2SIGMAR1
SCHEMBL726349 0.90 SLC6A2 (1.00) SLC6A4SLC6A3SLC6A2SMN1; SMN2SIGMAR1
SCHEMBL24221220 0.89 SLC6A4 (0.88) SLC6A4SLC6A3SLC6A2SMN1; SMN2SIGMAR1
Hydrochloric Acid SCHEMBL339982 0.89 SMN1; SMN2 (1.00) SLC6A4SLC6A3SLC6A2SMN1; SMN2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005067931-A2 DOPAMINE UPTAKE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISEASE DANIOLABS LIMITED (GB) 2005-07-28 WO disclosed